Recent research indicates that Retatrutide, specifically the 40mg amount , could offer a promising breakthrough in the approach of being overweight. Distinct from many current therapies, Retatrutide works as a double GIP and GLP-1 receptor agonist, potentially leading to greater reduction in weight